Fortitude Family Office’s scPharmaceuticals SCPH Stock Holding History

Fortitude Family Office’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-613	Closed	-$3.48K	–	2093
2025 Q3	$3.48K	Hold	613	–	–	﹤0.01%	962
2025 Q2	$2.34K	Buy	+613	New	+$1.9K	﹤0.01%	1116

Fortitude Family Office's SCPH Position: Q4 2025 in Review

Fortitude Family Office sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 613 shares — an estimated $3.48K sold.

Fortitude Family Office first reported a position in SCPH in Q2 2025 and held it in 2 quarters. The position peaked at $3.48K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Fortitude Family Office reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Fortitude Family Office sold 613 scPharmaceuticals shares in Q4 2025, an estimated $3.48K.
Fortitude Family Office first reported a position in scPharmaceuticals in Q2 2025 and held it in 2 quarters.
Fortitude Family Office's scPharmaceuticals position peaked at $3.48K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.